Author(s) Austin Russian, Stephen Appezzato
Live from Asembia AXS26, Austin Russian explains how access to rare disease treatments can be delayed.
In the first part of his interview with Pharmaceutical Commerce, live from Asembia AXS26 in Las Vegas, Austin Russian, SVP of Program Excellence at PANTHERx Rare, focuses on the operational factors that can delay patient access to rare disease therapies. As more orphan drugs enter the market, stakeholders are paying closer attention to how access is managed across an increasingly complex care journey…